Skip to main navigation Skip to search Skip to main content

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

Research output: Contribution to journalArticleAcademicpeer-review

19 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)75-80
JournalAlzheimer's & dementia : diagnosis, assessment & disease monitoring
Volume1
Issue number1
DOIs
Publication statusPublished - 2015

Cite this